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Wnt signaling regulates a variety of develop-
mental processes in animals. Although the
b-catenin-dependent (canonical) pathway is
known to control cell fate, a similar role for non-
canonical Wnt signaling has not been estab-
lished in mammals. Moreover, the intracellular
cascades for noncanonical Wnt signaling re-
main tobeelucidated.Here,wedelineateapath-
way in which Wnt3a signals through the Gaq/11
subunits of G proteins to activate phosphatidy-
linositol signaling and PKCd in the murine ST2
cells. Gaq/11-PKCd signaling is required for
Wnt3a-induced osteoblastogenesis in these
cells, and PKCd homozygous mutant mice ex-
hibit a deficit in embryonic bone formation. Fur-
thermore, Wnt7b, expressed by osteogenic
cells in vivo, induces osteoblast differentiation
in vitro via the PKCd-mediated pathway; abla-
tion of Wnt7b in skeletal progenitors results in
less bone in themouse embryo. Together, these
results reveal a Wnt-dependent osteogenic
mechanism, and they provide a potential target
pathway for designing therapeutics to promote
bone formation.
INTRODUCTION
The Wnt family of proteins are conserved from coelenter-
ate to human and regulate cell proliferation, fate specifica-
tion, polarity, and migration (Cadigan and Nusse, 1997;
Lee et al., 2006). In the canonical Wnt pathway (Huelsken
and Birchmeier, 2001; Wodarz and Nusse, 1998), WntDevelopmbinding to Frizzled receptors and the low-density lipopro-
tein receptor-related protein 5 or 6 (LRP5/6) in vertebrates
(Mao et al., 2001b; Pinson et al., 2000; Tamai et al., 2000)
stabilizes b-catenin and thereby activates transcription of
downstream target genes via lymphoid enhancer binding
factor-1 (Lef-1) and T cell factors (Tcf1, 3, 4). The ampli-
tude of signaling is fine tuned in part via negative feedback
mechanisms that include the secreted molecule Dickkopf
1 (Dkk1) (Glinka et al., 1998), itself a direct transcriptional
target of canonical Wnt signaling (Chamorro et al., 2005;
Niida et al., 2004). Dkk1 antagonizes the pathway by inter-
fering with LRP5/6 and Wnt interactions (Bafico et al.,
2001; Mao et al., 2001a; Semenov et al., 2001).
Wnts also signal through b-catenin-independent (non-
canonical) mechanisms to regulate morphogenesis during
vertebrate development (Veeman et al., 2003). Most nota-
bly, noncanonical Wnt signaling has been implicated in
convergence and extension of the body axis during em-
bryogenesis in Xenopus (Tada and Smith, 2000; Walling-
ford et al., 2000), zebrafish (Heisenberg et al., 2000), and
mice (Kibar et al., 2001; Wang et al., 2006). In addition,
noncanonical Wnt signaling was shown to regulate both
polarized extension and planar cell polarity (PCP) in the
mouse cochlea (Curtin et al., 2003; Kibar et al., 2001;Mon-
tcouquiol et al., 2003; Wang et al., 2005). Thus, noncanon-
ical Wnt signaling directs cell polarity and cell movement
in a variety of vertebrate species.
The intracellular cascade responsible for noncanonical
Wnt signaling in vertebrates is not well understood. Over-
expression of XenopusWnt5a, rat Frizzled 2, or a Xenopus
Dishevelled (Dvl) construct lacking the DIX domain
(XDshDDIX) in Xenopus or zebrafish embryos stimulated
calcium flux and PKC activity by activating phosphatidyli-
nositol signaling sensitive to pertussis toxin (Kuhl et al.,
2000; Sheldahl et al., 2003; Slusarski et al., 1997). How-
ever, the role of classic PKC is not known, although
PKCd, a novel PKC isoform, was shown to regulateental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 113
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naling (Kinoshita et al., 2003). Neither is it known whether
a similar signaling cascade operates in mammalian cells.
In addition, certain Wnts or Frizzled molecules were
found to activate the Rho family of small GTPases in
HEK293T cells and Xenopus embryos (Habas et al.,
2003; Habas et al., 2001). The pathway was implicated
in convergent extension in Xenopus embryos (Choi and
Han, 2002; Habas et al., 2001, 2003; Penzo-Mendez
et al., 2003), but a similar role has not been demonstrated
in mammals.
The importance of canonical Wnt signaling in bone is
supported by genetic evidence from mammals. In hu-
mans, loss- or gain-of-function mutations in LRP5 were
linked with the osteoporosis-pseudoglioma syndrome
(Gong et al., 2001) and a high-bone-density syndrome
(Boyden et al., 2002; Little et al., 2002), respectively.
Mice lacking LRP5 (LRP5/) (Kato et al., 2002) or
Wnt10b (Wnt10b/) (Bennett et al., 2005) exhibited
a postnatal low-bone-mass phenotype. Conversely,
mice lacking the Wnt antagonist secreted Frizzled-related
protein 1 (sFRP1/) developed more bone postnatally
(Bodine et al., 2004). Moreover, genetic deletion of b-cat-
enin from early osteoprogenitors resulted in a lack of ma-
ture osteoblasts in the mouse embryo (Day et al., 2005;
Hill et al., 2005; Hu et al., 2005; Rodda and McMahon,
2006), whereas forced activation of b-catenin greatly en-
hanced osteogenesis (Rodda and McMahon, 2006).
Specifically, b-catenin was shown to be required both
prior to Osterix (Osx) expression (Hu et al., 2005) and for
the progression of Osx-positive cells to mature osteo-
blasts (Rodda andMcMahon, 2006). Finally, b-catenin sig-
naling in more mature osteoblasts was found to indirectly
control bone mass by regulating osteoclast formation
through the control of Osteoprotegerin expression (Glass
et al., 2005).
A role for noncanonical Wnt signaling in bone has not
been described. Here, we report a Wnt-Gaq/11-PKCd non-
canonical pathway that operates in mammalian osteopro-
genitors to promote osteoblast development. We further
demonstrate that Wnt7b likely promotes bone formation
in the mouse in part via this mechanism.
RESULTS
Wnt3a Induces Osteoblastogenesis Coupled with
PKC Activation in ST2 Cells
To investigate the molecular mechanism underlying Wnt
signaling during osteoblast differentiation, we established
aWnt-responsive osteoblastogenesis system. Themurine
bone marrow-derived stromal cell line ST2 (Ogawa et al.,
1988), upon incubation with a conditioned medium con-
taining Wnt3a (hereafter called Wnt3a medium), ex-
pressed a markedly higher alkaline phosphatase (AP) ac-
tivity than cells cultured in a control conditioned medium
(hereafter called L medium) (Figure 1A). Real-time PCR re-
vealed that APmRNA levels steadily increased during the
first 3 days of Wnt3a treatment before reaching a plateau
(Figure 1C). Similarly, expression of bone sialoprotein114 Developmental Cell 12, 113–127, January 2007 ª2007 Else(Bsp) was activatedwithin the first 24 hr and reached a pla-
teau by 72 hr of Wnt3a treatment (Figure 1C). On the other
hand, osteocalcin (OC), a marker for mature osteoblasts,
was induced only after 96 hr of Wnt3a stimulation (Fig-
ure 1C). Interestingly, Wnt3a did not stimulate Runx2 ex-
pression, but it significantly induced Osterix (Osx) after
96 hr (Figure 1C). Moreover, in the presence of ascorbic
acid and b-glycerophosphate, Wnt3a induced the wide-
spread formation of mineralized nodules (Figure 1B). Fi-
nally, purified recombinant Wnt3a dose dependently
induced AP in ST2 cells in a serum-free medium (Fig-
ure 1D). Thus, Wnt3a is sufficient to induce osteoblast
differentiation in ST2 cells.
To identify downstream molecules responsible for Wnt-
induced osteoblastogenesis, a proteomics approach was
taken to compare protein profiles in ST2 cells cultured in
Wnt3a medium versus L medium. Meristoylated alanine-
rich C kinase substrate (MARCKS), a prototypic substrate
for protein kinase C (PKC) (Blackshear, 1993), was de-
tected at an increased level after 24 hr of Wnt3a stimula-
tion (Figure 1E, arrows), a result confirmed by western
analyses of total cell lysates (Figure 1F). As MARCKS is
known to redistribute from the plasma membrane to the
cytosol after phosphorylation (Arbuzova et al., 2002), the
cytosolic fractions of cells were therefore analyzed for
the levels of phosphorylated MARCKS by using a phos-
pho-specific antibody. These studies revealed that
MARCKS phosphorylation was markedly enhanced after
1 hr of incubation in Wnt3a medium, and that upregulation
was sustained for at least 24 hr (Figure 1G). In fact, when
cells were stimulated with purified Wnt3a without serum,
phospho-MARCKSwas readily detectable at 10min post-
stimulation, and levels steadily rose within the first hour
(Figure 1H). Thus,Wnt3a robustly inducesMARCKS phos-
phorylation in ST2 cells.
PKCdMediatesWnt3a-InducedOsteoblastogenesis,
Independent of b-Catenin
Induction of MARCKS phosphorylation prompted us to
examine the role of PKC in Wnt3a-induced osteoblasto-
genesis. The PKC family of serine and threonine protein ki-
nases consists of at least 11 members, including the clas-
sic PKC isoforms (a, b1, b2, g) activated by diacylglycerol
(DAG), phosphatidylserine, and Ca2+; the novel PKC sub-
family (d, 3, h, q) activated by DAG and phosphatidylser-
ine; and the atypical PKC isoforms (l, i, z) activated only
by phosphatidylserine (Newton, 1997). Ro-31-8220, an
inhibitor for all PKC isoforms, significantly impaired AP
induction by Wnt3a (Figure 2A). However, Go¨ 6976, an in-
hibitor specific for classic PKC, had no effect even at 10
mM (IC50 2.3 nM for PKCa, 6.7 nM for PKCb) (Figure 2A).
Similarly, the intracellular Ca2+ chelator BAPTA/AM did
not inhibit Wnt3a-induced AP expression (Figure 2A). In
addition, a peptide inhibitor specific for atypical PKC
(PKCz pseudosubstrate) also failed to inhibit Wnt3a-in-
duced osteoblastogenesis (data not shown). In contrast,
rottlerin, a selective inhibitor for PKCd and PKCq, signifi-
cantly reduced AP induction in a dose-dependent manner
(Figure 2A), but a PKCq pseudosubstrate had no effectvier Inc.
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Wnt-PKCd Signaling Promotes Bone FormationFigure 1. Wnt3a Induces Osteoblast Differentiation and MARCKS Phosphorylation via PKCd in ST2 Cells
(A) AP detection by substrate staining after incubation for 48 hr in conditioned medium.
(B) Detection of bone nodules by alizarin red after incubation for 14 days in mineralization medium.
(C) Real-time PCR assays of mRNA expressed as folds over GAPDH.
(D) AP expression in cells cultured for 48 hr in serum-free medium with recombinant Wnt3a.
(E) Upregulation of MARCKS (arrows) by Wnt3a.
(F) Western analyses of total MARCKS in whole-cell lysates from cells incubated in Wnt3a (W) or L medium.
(G) Western analyses of phospho-MARCKS in cytosolic fractions of cells.
(H) Western analyses of phospho-MARCKS in cytosolic fractions of cells incubated in serum-free medium. Wnt3a was used at 50 ng/ml, and rottlerin
was used at 5 mM.
Bar graphs: n = 3. Western signals are normalized to a-tubulin.(data not shown). The inhibition of osteoblastogenesis by
rottlerin was confirmed by real-time PCR of osteoblast
markers (Figure S1; see the Supplemental Data available
with this article online). Similarly, rottlerin inhibited
Wnt3a-induced AP activity in primary cultures of limb pri-
mordial cells, isolated from E13.5 mouse embryos and
containing osteoprogenitors but no mature osteoblasts
(Figure 2B). Moreover, rottlerin abolished Wnt3a-induced
MARCKS phosphorylation in ST2 cells (Figure 1H). Thus,
PKCd is required for Wnt3a-induced osteoblast differenti-
ation and MARCKS phosphorylation.
To determine whether inhibition of PKC interfered with
canonical Wnt signaling, we examined the potential effect
of Ro-31-8220 or rottlerin on Wnt3a-induced transcrip-
tional activation of a Lef1-luciferase reporter as well as
b-catenin stabilization. Not only did Ro-31-8220 not im-
pair Wnt3a-induced luciferase expression or b-catenin
stabilization, it synergized with Wnt3a (Figures 2C and
2D). The fact that Ro-31-8220 also inhibits GSK3b,Developma known negative regulator of canonical Wnt signaling,
may explain this observation. Similarly, rottlerin did not im-
pair Wnt3a-induced b-catenin stabilization (Figure 2D).
Thus, PKCd mediates Wnt-induced osteoblastogenesis
independent of canonical Wnt signaling.
To corroborate the role of PKCd, we knocked down its
expression with siRNA. Western analyses confirmed that
PKCd siRNA reduced the protein level of PKCd by
66% (Figure 3E). Importantly, the knockdown decreased
Wnt3a-induced AP induction by 50% (Figure 3A). Simi-
larly, overexpression of a dominant-negative form of
PKCd (PKCd-DC) by using a retroviral vector severely im-
paired Wnt3a-induced AP expression (data not shown).
Moreover, when cultured in a mineralization medium, cells
expressing PKCd-DC formed significantly fewer bone
nodules than control cells expressing GFP (Figures 3G
and 3H). These results support the conclusion that
PKCd activity is required in Wnt3a-induced osteoblast
differentiation.ental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 115
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Wnt-PKCd Signaling Promotes Bone FormationFigure 2. PKCd Is Required for Wnt3a-Induced Osteoblastogenesis, but Not for Canonical Wnt Signaling in ST2 Cells
(A) Effects of PKC inhibitors on Wnt3a-induced AP expression in cells incubated for 48 hr in conditioned medium.
(B) Wnt3a-induced AP expression, and inhibition by rottlerin in primary E13.5 limb primordial cells after 96 hr of incubation. 1, L medium; 2, Wnt3a
medium; 3, Wnt3a medium plus 5 mM rottlerin.
(C) Effect of Ro-31-8220 on Wnt3a-induced expression of Lef1-luciferase reporter.
(D) Western analyses of b-catenin in cytosolic fractions of cells after incubation in Wnt3a (W) or L medium, with or without 5 mM rottlerin (Rott) or
Ro-31-8220 (Ro). When inhibitors were used, cells were pretreated with inhibitor for 1 hr in normal growth medium. Bar graphs: n = 3. The b-catenin
level was normalized to a-tubulin.Gq-Activated Phosphatidylinositol Signaling,
Independent of b-Catenin, Mediates Wnt3a-Induced
Osteoblastogenesis
Wenext set out to unravel the signaling cascade leading to
PKCd activation in response to Wnt3a. PKCd is activated
by DAG, which is, in turn, produced through hydrolysis
of phosphatidylinositol 4,5-bisphosphate (PIP2) by phos-
pholipase C (PLC). Since the PLC-b isoenzymes are acti-
vated by both the Gq subfamily of a subunits and the
bg subunits of heterotrimeric G proteins (Morris and
Malbon, 1999), we examined whether G protein-linked
phosphatidylinositol signaling was responsible for Wnt3a-
induced PKCd activation and subsequent osteoblasto-
genesis. Pertussis toxin, which catalyzes ADP ribosylation
of the Gi family of the a subunits, thus uncoupling
them from their activating receptors, is known to inhibit
PLC-b activation by the bg subunits (Morris and Mal-
bon, 1999). The toxin, however, did not inhibit Wnt3a-
induced osteoblast differentiation in ST2 cells (data not
shown). We therefore focused subsequent studies on Gq
signaling.
To examine the role of Gq signaling in Wnt-induced os-
teoblastogenesis, we took advantage of a dominant-neg-
ative reagent, GqI, which is a COOH-terminal peptide (aa
305–359) of Gaq previously shown to partially inhibit Gq
signaling (Akhter et al., 1998). GqI expression significantly
reduced Wnt3a-induced AP expression (Figure 3B), as
well as bone nodule formation (Figures 3I and 3J). Thus,116 Developmental Cell 12, 113–127, January 2007 ª2007 ElsGq signaling likely mediates Wnt3a-induced osteoblasto-
genesis.
To confirm the role of the Gq subfamily of a subunits, we
reduced the levels of Gaq and Ga11, two widely expressed
members, with siRNA. A combination of siRNA oligonu-
cleotides against Gaq or Ga11 reduced their combined
protein levels by 43%, as detected by an antibody rec-
ognizing both molecules (Figure 3F). Importantly, these ol-
igonucleotides reducedWnt3a-induced AP expression by
>50% (Figure 3C). Similarly, single knockdowns of either
Gaq or Ga11 also partially inhibited AP induction (data
not shown). Thus, both Gaq and Ga11 are likely to mediate
Wnt3a-induced osteoblast differentiation.
To further test the function of phosphatidylinositol sig-
naling, we examined the effect of U73122, a PLC inhibitor,
on Wnt3a-induced osteoblastogenesis. U73122 not only
inhibited AP induction by 50% (Figure 3D), but it also re-
duced bone nodule formation (Figures 3K and 3L). Thus,
PLC activity is important for Wnt-induced osteoblast
differentiation.
Next, we examined whether inhibition of Gq signaling or
PLC activity affected Wnt3a-induced PKCd activation or
b-catenin stabilization. Both U73122 (Figure 3M) and GqI
(Figure 3N) markedly reduced phospho-MARCKS, with-
out significantly altering b-catenin stabilization. These re-
sults indicate that Wnt3a activates a Gaq/11/ PLCb/
PKCd pathway independent of b-catenin signaling to
promote osteoblast differentiation.evier Inc.
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Wnt-PKCd Signaling Promotes Bone FormationFigure 3. PKCd Activation via Gq Signaling Promotes Wnt3a-Induced Osteoblastogenesis and Requires Dvl in ST2 Cells
(A–D) AP expression in cells incubated for 48 hr in conditioned medium. In (A) and (C), cells transfected with siRNA were incubated in normal growth
medium for 96 hr before being cultured in conditioned medium. In (B), cells were first infected with retrovirus before being incubated in conditioned
medium. n = 3.
(E and F)Western analyses for (E) PKCd and (F) Gaq/Ga11 in whole-cell lysates of cells at 96 hr after siRNA transfection, withGAPDH siRNA as control.
(G–L) Detection of bone nodules by alizarin red. In (G)–(J), cells were infected with retrovirus before being incubated in Wnt3a-mineralization medium.
U73122 was used at 5 mM.
(M andN)Western analyses for b-catenin and phospho-MARCKS in cytosolic fractions. Cells prestarved for 24 hr were cultured in serum-freemedium
for 1 hr with or without recombinant Wnt3a. In (N), cells were first infected with viruses, and then starved for 24 hr before Wnt3a stimulation.
Western signals were normalized to a-tubulin.PKCd Activation by Wnt3a Requires Dvl, but Is
Insensitive to Dkk1
We next examined whether PKCd activation involves the
Dvl family of molecules. Immunostaining revealed that in
unstimulated ST2 cells, both PKCd and Dvl-2 were pres-
ent diffusely in the cytosol (Figures 4E–4G). However,
within 30 min of Wnt3a stimulation, both molecules were
translocated to the plasma membrane in a punctate pat-
tern, although some signal remained in the perinuclear re-
gion (Figures 4A and 4B). Remarkably, PKCd and Dvl-2
colocalized at the plasma membrane (Figure 4C). Similar
results were observed with Dvl-1 and Dvl-3 (Figures S2
and S3). Thus, Wnt3a signaling translocates PKCd and
Dvl to common domains within the plasma membrane.
To determine the kinetics ofmembrane translocation for
PKCd and Dvl-2, we used western analyses to quantify theDevelopmlevels of these proteins in the cytosol after Wnt3a stimula-
tion. At 10 min poststimulation, both PKCd and Dvl-2 were
markedly reduced in the cytosol (Figure 4I, lane 2). At 30
min, the cytosolic content of PKCd or Dvl-2 was partially
recovered but remained significantly lower than the pres-
timulation level (Figure 4I, lane 3). Interestingly, at 60 min,
both proteins were present in the cytosol at a higher than
prestimulation level (Figure 4I, lane 4). Consistent with ac-
tivation of PKCd at the cell membrane, the levels of phos-
pho-MARCKS in the cytosol steadily rose within the first
hour of stimulation (Figures 1H and 4I). Thus, concurrent
with PKCd activation, Wnt3a signaling acutely and tran-
siently translocates PKCd and Dvl-2 to the plasma mem-
brane with similar kinetics.
We next examined whether Dvl signaling is required for
PKCd activation. Since the DIX, PDZ, and DEP domainsental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 117
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Wnt-PKCd Signaling Promotes Bone FormationFigure 4. PKCd Activation byWnt3a Correlates with Dvl-2 Translocation to the PlasmaMembrane and Is Insensitive to Dkk1 in ST2
Cells
(A–H) Immunostaining of PKCd and Dvl-2 in cells (A–D) with or (E–H) without Wnt3a stimulation. In (D) and (H), cells were infected with a retrovirus
coexpressing Dkk1 and nuclear GFP (Dkk1-GFP).
(I–J) Western analyses in cytosolic fractions. Cells were prestarved in serum-free medium for 24 hr before being stimulated with recombinant Wnt3a
for (I) the indicated times or for (J) 1 hr. In (J), cells were first infected with retroviruses expressing either GFP or Dkk1 before starvation. Signal levels
were normalized to a-tubulin.
(K) The effect of Dkk1 on Lef1-luciferase activation by Wnt3a. n = 3.were reported to preferentially mediate distinct Wnt path-
ways, we set out to evaluate whether overexpression of
Dvl-2 variants lacking one of the three conserved domains
(DDIX, DPDZ, and DDEP) (Habas et al., 2001) differentially
affects Wnt3a-induced PKCd activation versus b-catenin
stabilization. Cells expressing any of the Dvl-2 variants
showed a marked reduction in MARCKS phosphorylation
(Figure 3N). Similarly and unexpectedly, all three Dvl-2
variants also inhibited b-catenin accumulation (Figure 3N).
These results support the conclusion that Dvl proteins are
required for both PKCd activation and b-catenin stabiliza-
tion in response to Wnt3a, and that all three conserved
domains may participate in both pathways.
To determine whether the Wnt-PKCd pathway requires
LRP5/6 signaling, we examined whether the membrane
translocation of PKCd in response to Wnt3a is sensitive
to Dkk1 inhibition. Here, cells infected with a retrovirus co-
expressing Dkk1 and nuclear GFP were immunostained118 Developmental Cell 12, 113–127, January 2007 ª2007 Elsefor endogenous PKCd, with or without Wnt3a stimulation.
As in control cells (Figure 4A), Wnt3a induced characteris-
tic translocation of PKCd from the cytosol (Figure 4H) to
the plasma membrane (Figure 4D) in cells overexpressing
Dkk1. Thus, Dkk1 does not inhibit Wnt3a-induced mem-
brane translocation of PKCd.
We next examined whether Dkk1 inhibits Wnt3a-in-
duced PKCd activation. To this end, cytosolic proteins
from virally infected cells with or without Wnt3a stimula-
tion were assayed for phospho-MARCKS by western
analyses. As a control for the efficacy of the Dkk1 virus,
b-catenin levels were also analyzed. In addition, the virally
infected cells were transfected with the Lef1-luciferase
reporter and were assayed for response to Wnt3a. As
expected, in Dkk1-overexpressing cells, Wnt3a failed to
either stabilize b-catenin (Figure 4J) or activate transcrip-
tion of the reporter (Figure 4K). On the other hand,
Wnt3a induced phosphorylation of MARCKS in these cellsvier Inc.
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Thus, in contrast to the canonical Wnt pathway, Wnt-
PKCd signaling does not appear to engage the LRP5/6
coreceptors.
Genetic Deletion of PKCd Results in a Reduction
in Embryonic Bone Formation
To determine the role of PKCd in bone formation in vivo,
we analyzed the skeleton of PKCd knockout mice
(PKCd/). The PKCd/ animals are viable and fertile
but were reported to exhibit hyperactivation of B cell pro-
liferation and auto-immunity (Miyamoto et al., 2002), as
well as deficiency in stress-induced apoptosis of blood
vessel smooth muscle cells (Leitges et al., 2001). We rea-
soned that removal of PKCdmight lead to quantitative de-
fects more evident during early phases of bone formation,
and we therefore focused our analyses on early embryos.
At E15.5, the wild-type embryos showed obvious ossifica-
tion in the maxilla, the mandible, the ribs, and the limbs
(Figure 5A). In contrast, PKCd/ littermates exhibited
much less ossification (Figure 5B). In particular, themaxilla
and themandible ofmutant embryos showed onlyminimal
mineralization compared with wild-type littermates (Fig-
ure 5, compare [C] and [D]). In limbs, bone collars of ossi-
fying skeletal elements were notably shorter in the mutant
embryo (Figure 5E). Accordingly, von Kossa staining on
sections of long bones showed that bone collars were
shortened in mutants at both E14.5 and E15.5 (Figure 5F).
Indeed, the relative bone collar length normalized to the
total skeletal element length was significantly reduced in
the mutant (Figure 5G). Thus, removal of PKCd results in
less bone in the early embryonic skeleton.
As bone collar formation in the embryo is coupled with
cartilage development, we examined the status of chon-
drocyte maturation in PKCd/ versus wild-type litter-
mates. At E14.5, in mutant embryos, the hypertrophic
zone expressingCola1(X)was shortened; the domains ex-
pressing parathyroid hormone-related peptide-receptor
(PTHrP-R) and Indian hedgehog (Ihh) were less well sepa-
rated, and the terminal hypertrophic zone expressing
matrix metalloproteinase 13 (MMP 13) was reduced (Fig-
ure 5H). Thus, loss of PKCd delays chondrocyte matura-
tion in long bones.
We next examined whether progression of osteoblast
differentiation was perturbed in PKCd/ embryos. To
this end, we took advantage of the fact that osteoblasto-
genesis in the perichondrium of long bones progresses
linearly along the epiphysis to diaphysis axis. In particular,
the onset of expression for later osteoblast markers is
coupled with chondrocyte maturation, resulting in charac-
teristic positioning of the leading edge in relation to the hy-
pertrophic cartilage. Thus, we examined the expression of
a panel of osteoblast markers in the perichondrium by in
situ hybridization, and we evaluated whether their posi-
tioning against the Cola1(X)-expressing hypertrophic
chondrocytes on adjacent sections was altered in
PKCd/ versus wild-type littermates at E15.5. In the
wild-type embryo, the early markers AP (Figure 5I, arrow),
Cola1(I), and Runx2 (data not shown) were detectedDevelopmthroughout much of the metaphyseal perichondrium. On
the other hand, Osx and Bsp were activated in perichon-
drial cells immediately preceding the hypertrophic region,
with their leading edges (orange, vertical lines) positioned
at a characteristic distance from the first row of Cola1(X)-
positive cells (purple, vertical line) (Figure 5I). In the
PKCd/embryo, the expressionpatterns ofAP (Figure 5I),
Cola1(I), and Runx2 (data not shown) were similar to those
in the wild-type littermates. However, the leading edges of
Osx andBsp (green, vertical lines) were significantly closer
to the boundary of the hypertrophic zone (purple, vertical
line) (Figure 5I). Thus, removal of PKCd appears to delay
the onset of Osx expression in the osteoblast lineage,
which may, in turn, impede subsequent differentiation.
To confirm that loss of PKCd results in intrinsic deficits in
osteoblast differentiation, we performed in vitro osteo-
blastogenesis assays with primary cell cultures. We first
assayed for bone nodule formation by E13.5 limb primor-
dial cells.PKCd/ cells produced significantly fewer bone
nodules than normal cells (Figure 5, compare [K] and [L]),
but instead generated more cartilage nodules (Figure 5,
compare [M] and [N]). Secondly, we assayed for AP pro-
duction by primary bone marrow stromal cells (BMSCs)
in culture. Here, PKCd/ BMSCs showed a significantly
lower level than wild-type cells (Figure 5O). These results
therefore support the conclusion that PKCd in skeletal
progenitor cells promotes osteoblast differentiation.
Lastly, we examinedMARCKS phosphorylation levels in
the cytosol of E14.5 limb primordial cells. The level of
phospho-MARCKS was markedly lower in PKCd/ cells
than in wild-type cells (Figure 5J). Thus, MARCKS is likely
an endogenous substrate of PKCd in vivo.
Wnt7b Induces Osteoblastogenesis via
a Noncanonical, PKCd-Dependent Mechanism
To assess the physiological relevance of Wnt-PKCd sig-
naling in bone formation, we investigated whether
Wnt7b, a ligand expressed by osteogenic cells in vivo
and able to induce osteoblast differentiation in vitro (Hu
et al., 2005), signals through this pathway. In keeping
with the previous finding, overexpression of Wnt7b, either
by transient transfection (Figure 6F) or by viral infection
(Figure 6G), induced AP expression in the multipotent
mouse embryonic mesenchymal cell line C3H10T1/2
(Taylor and Jones, 1979). Moreover, Wnt7b overexpres-
sion induced formation of bone nodules in both
C3H10T1/2 and ST2 cells in mineralization medium
(Figure 6A). Finally, Wnt7b also induced osteoblast differ-
entiation in primary cultures of E13.5 limb primordial cells
(Figure 6H). Interestingly, in the limb cells, Wnt7b induced
more robust osteoblastogenesis than a dominant active
form of b-catenin (daßcat) (Figure 6H), even though
>90% cells expressed daßcat, as judged by coexpression
of GFP (data not shown). Thus, Wnt7b activates the oste-
ogenic program in multiple cell systems, and activation
may include alternative pathways to that mediated by
b-catenin.
We next examined whether Wnt7b activates the canon-
ical or the PKCd pathway in the cell cultures. Wnt7b failedental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 119
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Wnt-PKCd Signaling Promotes Bone FormationFigure 5. Removal of PKCd Results in a Deficit in Embryonic Bone Formation
(A–E) Whole-mount skeletal staining of wild-type and PKCd/ littermates at E15.5. Bone stained red; cartilage stained blue. Vertical lines in (E) de-
marcate the ends of the bone collar; the horizontal, red line denotes the deficit in the mutant. R, ribs; Mx, maxilla; Mb, mandible.
(F) von Kossa staining on longitudinal sections of E14.5 humerus and E15.5 radius in wild-type versus PKCd/ littermates. Vertical lines demarcate
the ends of the bone collar; the horizontal, red line denotes the deficit in the mutant. Double-headed arrows indicate the lengths of the bone collar (x)
and the total radius (y).
(G) Relative bone length (x/y) in the radius of E15.5 wild-type versus PKCd/ embryos. n = 4, p < 0.001.
(H) In situ hybridization for chondrocyte markers on longitudinal sections of the humerus in wild-type versus PKCd/ E14.5 littermates. Vertical lines
denote the ends of the Cola1(X)-expressing domain in the wild-type embryo. Double-headed arrows indicate the wild-type distance between two
major PTHrP-R and Ihh expression domains. Asterisk, PTHrP-R signal in skin; arrow, MMP13 signal in the osteoblast-lineage cell.
(I) In situ hybridization for osteoblast markers on longitudinal sections of tibia in wild-type versus PKCd/ littermates at E15.5. Adjacent sections are
used for each genotype. Purple, vertical lines: leading edge of the Cola1(X)-expressing domain; orange, vertical lines: leading edge of Osx or Bsp in
wild-type embryo; green, vertical lines: leading edge of Osx or Bsp in the PKCd/ embryo; red, horizontal lines: deficit in the PKCd/ embryo.
Arrows, signal in perichondrium.
(J) Western analyses of cytosolic fractions of limb primordial cells from E14.5 wild-type versus PKCd/ littermates.
(K–N) Detection of (K and L) bone and (M and N) cartilage nodules in primary cultures of limb primordial cells from E13.5 (K andM) wild-type versus (L
and N) PKCd/ embryos. Bone nodules stained dark red; cartilage nodules stained blue. Relative nodule numbers between normal and mutant
genotypes were indicated.
(O) AP expression by wild-type versus PKCd/ BMSCs at 72 hr after confluence. n = 3.to activate Lef1-Luciferase expression in either ST2 or
C3H10T1/2 cells, even though Wnt3a and daßcat greatly
stimulated expression (Figures 6B and 6C). Accordingly,
Wnt7b failed to stabilize b-catenin in C3H10T1/2 cells
(Figure 6E, top panel). On the other hand, Wnt7b induced
MARCKS phosphorylation in both ST2 (Figure 6D) and120 Developmental Cell 12, 113–127, January 2007 ª2007 ElsC3H10T1/2 cells (Figure 6E). Thus, Wnt7b does not stim-
ulate canonical Wnt signaling in either ST2 or C3H10T1/2
cells, but it activates PKCd in both cell types.
We then evaluated the potential role of canonical versus
PKCd signaling in Wnt7b-induced osteoblastogenesis.
Coexpression of Dkk1 did not impair AP induction byevier Inc.
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Wnt-PKCd Signaling Promotes Bone FormationFigure 6. Wnt7b Induces Osteoblastogenesis and PKCd Activity, but Does Not Activate Canonical Wnt Signaling
(A) Detection of bone nodules by alizarin red in ST2 and C3H10T1/2 cells expressing GFP or Wnt7b.
(B and C) Lef1-luciferase activation by Wnt3a, Wnt7b, or daßcat. In (B), Wnt7b was virally expressed, whereas Wnt3a was present in conditioned
medium. In (C), cells were cotransfected with the reporter and a daßcat- or Wnt7b-expressing plasmid or with the empty expression vector pCIG.
n = 3.
(D and E) Western analyses in cytosolic fractions of (D) ST2 or (E) C3H10T1/2 cells virally expressing GFP or Wnt7b, after incubation in serum-free
medium for 24 hr. Western signals were normalized to GAPDH.
(F–H) AP expression in (F and G) C3H10T1/2 or (H) primary cultures of E13.5 limb primordial cells. Cells either (F) transiently transfected or (G and H)
virally infected were cultured in normal growth medium for (F and G) 48 hr or (H) 72 hr. n = 3.Wnt7b in either C3H10T1/2 (Figure 6G) or the primary limb
primordial cells (data not shown). However, rottlerin
strongly inhibited Wnt7b-induced AP activity in both cell
types (Figure 6G and data not shown). Thus, Wnt7b in-
duces osteoblast differentiation in multiple cell systems
via the PKCd-mediated noncanonical mechanism.
Genetic Ablation of Wnt7b Results in Deficiency
in Embryonic Bone Formation
To assess the physiological role of Wnt7b in bone forma-
tion, we genetically removedWnt7b from the skeletal pro-
genitors by using the Cre-loxP technique. An initial report
examining E18.5 embryos devoid of Wnt7b failed to show
any clear skeletal phenotype (Rodda and McMahon,
2006). Here, we generated Wnt7b mutant mice (Dermo1-
Cre; Wnt7bn/c3) carrying a Wnt7b null allele (Wnt7bn)
(Parr et al., 2001), a Wnt7b conditional allele (Wnt7bc3;
J.R., T.J.C., and A.P.M., unpublished data), and also
a Dermo1-Cre allele (Yu et al., 2003). The Wnt7bc3 allele
had loxP sites flanking the essential exon 3 and functioned
as a null allele upon recombination by Cre (to be reported
elsewhere). Wnt7b mutant animals were viable after birthDevelopand had no obvious phenotype. However, whole-mount
skeletal staining revealed that, at E15.5, when wild-type
embryos showed obvious ossification, Wnt7b mutant lit-
termates exhibited a diminution in ossification, while
somemutant embryos also appeared to be slightly smaller
(Figure 7A). Regardless of the overall size, the bone collar
of long bones was consistently shorter in mutant
littermates (Figure 7B), as confirmed by quantitation of
the relative bone collar length over total length of the ele-
ment (Figure 7C). At E18.5, mutant skulls exhibited less
alizarin red staining and widened sutures (Figure 7D).
Thus, Wnt7b deficiency results in less bone in mouse
embryos.
We next examined whether chondrocyte maturation
was perturbed in Wnt7b mutants. At E14.5, the overall
length of the hypertrophic zone expressing Cola1(X) was
similar between mutant and wild-type littermates (Fig-
ure 7F). However, in mutants, the domains expressing
PTHrP-R or Ihhwere less well separated, and the terminal
hypertrophic region expressing MMP13 was clearly re-
duced. At E15.5, the distance between the two Cola1(X)-
expressing domains was significantly reduced in themental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 121
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Wnt-PKCd Signaling Promotes Bone FormationFigure 7. Removal ofWnt7b in Skeletal Cells Results in Defects in Bone Formation
(A) Whole-mount skeletal staining of wild-type (WT) orWnt7bmutant (MT1 andMT2) littermates at E15.5. Note the smaller size ofMT2. Representative
bones shown at a higher magnification below the corresponding whole skeleton. R, ribs; Mx, Maxilla; Mb, mandible; s, scapula; h, humerus; c,
clavicle.
(B) von Kossa staining on longitudinal sections of humerus in wild-type (WT) versusWnt7bmutant (MT) E15.5 littermates. Vertical lines demarcate the
length of the bone collars; the horizontal line denotes the deficit in the mutant embryo.
(C) Relative bone length (bone collar over total length) in the humerus of wild-type versus Wnt7b mutant E14.5 littermates. n = 5; p < 0.001.
(D) Skulls of wild-type (WT) orWnt7bmutant (MT) littermates at E18.5. Boxed regions are shown at a higher magnification below. The white contour
demarcates sutures; the arrow denotes a nearly fused suture.
(E) Western analyses of cytosolic fractions of limb primordial cells from wild-type versus Wnt7b mutant E14.5 littermates.
(F) In situ hybridization for chondrocyte markers on longitudinal sections of the humerus from wild-type (WT) versus Wnt7b mutant (MT) embryos.
Vertical lines denote the ends of the Cola1(X)-expressing domain in the wild-type embryo. Double-headed arrows indicate the wild-type distance
between the two major PTHrP-R, Ihh, or Cola1(X) expression domains. Asterisk, PTHrP-R signal in skin.
(G) In situ hybridization for osteoblast markers on longitudinal sections of the humerus in wild-type versus Wnt7b mutant (MT) E15.5 littermates.
Adjacent sections were used for each genotype. Purple, vertical lines: leading edge of the Cola1(X)-expressing domain in each genotype; orange,
vertical lines: leading edge of Osx, PTHrP-R, or Bsp in wild-type; green, vertical lines: leading edge of Osx, PTHrP-R, or Bsp in the MT embryo;
red, horizontal lines: deficit in the MT embryo. Arrows, signal in perichondrium; asterisks, signal in chondrocytes.
(H) Detection of bone nodules in primary cultures of calvarial cells or bone marrow stromal cells (BMSCs) from wild-type (WT) orWnt7bmutant (MT)
littermates.
(I) In situ hybridization for Dkk1 and Tcf1 on longitudinal sections of the humerus at E15.5. Asterisks, signal in chondrocytes; arrows, signal in
perichondrium; PH, prehypertrophic chondrocytes.
(J) Wnt7b signals through a Gaq/11/ PLCb/ PKCd pathway to stimulate progression from Runx2- to Osx-expressing cells during osteoblasto-
genesis.mutant. Thus, loss of Wnt7b appears to delay subsequent
maturation of chondrocytes after the initiation of Cola1(X)
expression.
To examine potential intrinsic defects in the osteoblast
lineage, we assayed the expression of AP, Bsp, Runx2,
Osx, and PTHrP-R in relation to Cola1(X) on adjacent sec-122 Developmental Cell 12, 113–127, January 2007 ª2007 Elsetions of E15.5 long bones.WhereasAP andRunx2 expres-
sion in the perichondrium was indistinguishable between
mutant and wild-type littermates, the leading edges for
Osx, PTHrP-R, and Bsp were consistently closer to the
boundary of the hypertrophic zone in the mutant
(Figure 7G). Thus, removal of Wnt7b, similar to that ofvier Inc.
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osteoblast differentiation.
To determine whether removal of Wnt7b disrupted ca-
nonical Wnt signaling in long bones, we performed in
situ hybridization for Dkk1 and Tcf1, two known target
genes of the pathway. Both molecules were expressed
normally inWnt7bmutant embryos (Figure 7I). In contrast,
the limb primordial cells from E14.5 mutant embryos con-
tained a significantly lower level of phospho-MARCKS
than wild-type littermates (Figure 7E), indicating that
Wnt7b stimulates MARCKS phosphorylation in vivo.
Thus, the bone defect inWnt7bmutant embryos is unlikely
due to disruption of canonical Wnt signaling, but it ap-
pears to correlate with impairment in PKCd activation.
To confirm that Wnt7b directly regulates osteoblast dif-
ferentiation, we evaluated Wnt7b-deficient cells for their
ability to differentiate in vitro. We utilized calvarial cells
from neonates, as well as BMSCs from adult mice, both
of which contain osteoblast precursors. In both cases,
Wnt7b-deficient cells produced significantly fewer bone
nodules than wild-type cells (Figure 7H). These results
are consistent with the notion that endogenous Wnt7b
promotes osteoblast differentiation from progenitors.
In summary, to our knowledge, the present study re-
veals a novel osteogenic pathway in which Wnt mole-
cules, such as Wnt7b, signal through the Gq family of G
protein a subunits to activate PKCd, which, in turn, pro-
motes the transition from Runx2- to Osx-expressing cells
(Figure 7J).
DISCUSSION
We have delineated a noncanonical Wnt pathway that op-
erates in mammalian osteoblast precursors to promote
bone formation. In this pathway, Wnt activates the G pro-
tein-linked phosphatidylinositol signaling and subse-
quently PKCd, via a mechanism that requires Dvl but is in-
sensitive to Dkk1. Several lines of evidence support that
Wnt7b, expressed in osteogenic tissues in vivo, stimulates
osteoblast differentiation, likely through the PKCd-medi-
ated pathway. First, genetic ablation of either Wnt7b or
PKCd delayed the onset of Osx expression and reduced
embryonic bone; second, Wnt7b- or PKCd-deficient
osteoprogenitors were defective in osteoblastogenesis
in vitro; third, deletion of either gene reduced MARCKS
phosphorylation in vivo.
G Proteins and Wnt Signaling
Although the Gao subunit was recently found to mediate
both theWnt and the planar polarity pathway inDrosophila
(Katanaev et al., 2005), the role of G proteins inWnt signal-
ing in mammals is not clear. In mouse F9 teratocarcinoma
cells, overexpression of chimeric receptors between the
b2-adrenergic receptor and rat Frizzled 1 or 2, was re-
ported to activate the canonical Wnt pathway (Liu et al.,
2001) or decrease intracellular cGMP (Ahumada et al.,
2002), respectively, both in a pertussis toxin-sensitive
manner. More recently, both Gao and Gaq were found to
mediate Wnt3a-induced stabilization of b-catenin in cellDevelopmcultures (Liu et al., 2005). However, the physiological rele-
vance of these findings is not known. Finally, adenylyl cy-
clase signaling was implicated in Wnt-induced myogene-
sis (Chen et al., 2005), but a direct role of G proteins
remains to be confirmed.
The present study indicates that the Gq family of a sub-
units is required for Wnt-induced PKCd activation, but not
b-catenin stabilization in osteoprogenitors, and that Gq
signaling is important for Wnt-induced osteoblast differ-
entiation. These conclusions are supported by studies
with a dominant-negative reagent (GqI) and specific siRNA
oligonucleotides against Gaq and Ga11. Of note, mice
missing both alleles ofGaq and one copy ofGa11 (Gaq
/;
Ga11
+/) developed to term, but exhibited severe bone de-
fects in the craniofacial skeleton (Offermanns et al., 1998).
In addition, in Xenopus embryos, Gq, but not Gi, signaling
mediated XWnt8a-induced axis duplication as well as me-
soderm ventralization (Wu et al., 2000), although it was not
clear whether in that system Gq signaled through b-cate-
nin or an alternative pathway. Finally, it may be of interest
to examine whether similar G protein signaling mediates
cardiomyocyte differentiation induced by Wnt11, previ-
ously reported to be independent of b-catenin signaling
(Koyanagi et al., 2005; Pandur et al., 2002).
Canonical versus Noncanonical Wnt Signaling
The mechanism for activating canonical versus nonca-
nonical pathways by Wnt molecules is not clear. Wnt3a
signaled through both the b-catenin and the PKCd path-
way in ST2 cells, whereas Wnt7b selectively activated
the later in multiple cell types. The two pathways differed
not only in their dependence on the LRP5/6 coreceptor,
but also in their requirement for Gq signaling. This could in-
dicate that Wnt3a induces the formation of two distinct
signaling complexes or a single complex with dual signal-
ing properties. The specificity of signaling complexes may
be dictated by the Frizzled receptor(s), as forced expres-
sion of mouse Frizzled 4 in HEK293 cells (Mikels and
Nusse, 2006) or human Frizzled 5 in Xenopus embryos
(He et al., 1997) was sufficient to transduce canonical sig-
naling by Wnt5a, which was otherwise inactive in this re-
gard. Moreover, overexpression of different mouse Friz-
zled molecules in the Xenopus embryo was found to
activate either classic PKC or downstream target genes
of b-catenin (Sheldahl et al., 1999). Finally, Wnts may sig-
nal through receptors other than Frizzleds, such as the
atypical receptor kinase Ryk (Lu et al., 2004; Schmitt
et al., 2006) or the orphan receptor tyrosine kinase Ror2
(Mikels and Nusse, 2006). Identification of responsible
Frizzled or alternative receptors for different Wnts under
physiological conditions will help to elucidate the mecha-
nism for Wnt ligands to generate distinct signals.
Wnt7b, PKCd, and Bone Formation
Consistent with the role of Wnt-PKCd signaling in osteo-
blastogenesis in vitro, genetic ablation of either Wnt7b
or PKCd resulted in a deficit in bone formation in the
mouse embryo. Nonetheless bone formed in both mu-
tants. The modest phenotype could reflect overlappingental Cell 12, 113–127, January 2007 ª2007 Elsevier Inc. 123
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blastogenesis. Alternatively, Wnt-PKCd signaling could
represent a mechanism that augments other osteogenic
signals, but itself is not essential for osteoblast differenti-
ation in vivo. In this scenario, the noncanonical pathway
appears to perform a function distinct from that of canon-
ical Wnt signaling, as thus far inferred from genetic studies
of b-catenin (Day et al., 2005; Hill et al., 2005; Hu et al.,
2005; Rodda and McMahon, 2006).
Themechanism for Wnt7b and PKCd to regulate the on-
set of Osx expression is presently unknown. Although an
immediate target of Wnt-PKCd signaling, MARCKS has
not been implicated in bone formation. The MARCKS/
mice had severe defects in neural development and ex-
hibited perinatal lethality (Stumpo et al., 1995), but analy-
ses of the skeletons of these mutant embryos have so far
not revealed any obvious defects (data not shown). It is
possible that other PKCd substrates mediate osteoblast
differentiation.
Frizzled-G Protein Signaling as a Target for Bone
Anabolic Therapeutics
The present study identified a novel, to our knowledge,
mechanism for Wnt signals to stimulate bone formation.
Importantly, this pathway can be uncoupled from canoni-
cal Wnt signaling and is mediated through specific G pro-
teins that are likely coupled with the Frizzled receptors.
Thus, reagents that selectively activate G protein signaling
by the relevant receptors may provide specific bone ana-
bolic effects.
EXPERIMENTAL PROCEDURES
Plasmids and Oligonucleotides
Full-lengthWnt7b cDNA was purchased from ATCC. The Lef1-lucifer-
ase reporter (Mao et al., 2001b) and the cDNAs for the dominant active
form of b-catenin (Tetsu and McCormick, 1999), GqI (Akhter et al.,
1998), and Dvl-2 derivatives (Habas et al., 2001) were as previously de-
scribed. The full-length cDNA for PKCd was cloned by PCR from
a mouse E15 Marathon-Ready cDNA pool (BD Biosciences Clontech),
and the cDNA for the truncated form (PKCd-DC, aa 1–338) was gener-
ated by a second PCR from the full-length cDNA. The siRNA oligonu-
cleotides for PKCd were purchased from Dharmacon, and those for
Gaq and Ga11 were purchased from Ambion.
Antibodies, Proteins, and Chemicals
The polyclonal antibodies against PKCd and MARCKS; the monoclo-
nal antibodies against a-tubulin, Dvl-1, Dvl-2, and Dvl-3; and the
HRP-conjugated secondary antibodies were purchased from Santa
Cruz Biotechnology. The monoclonal antibodies against glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) and b-catenin were pur-
chased from Chemicon and BD Biosciences Pharmigen, respectively.
The polyclonal antibody against phospho-MARCKS was purchased
from Cell Signaling. The polyclonal antibody against Gaq and Ga11
was purchased from Calbiochem. The Alexa 488- or 555-conjugated
secondary antibodies were purchased from Molecular Probes. Puri-
fied recombinant Wnt3a was purchased from R&D systems. All inhib-
itors for PKC and PLC were purchased from Calbiochem.
Cell Cultures
C3H10T1/2 cells, Wnt3a-expressing cells, and control L cells were
obtained from ATCC and were maintained in BME with 10% bovine
serum (Atlas) as per instructions. ST2 cells (Dr. Steve Teitelbaum,124 Developmental Cell 12, 113–127, January 2007 ª2007 ElseWashington University) were maintained in a-MEM (Sigma). Unless
otherwise indicated, ST2 cells were seeded at 1.5 3 104 cells/cm2
overnight before experiments. Wnt3a- and L-conditioned medium
were used at 1:2 dilution in normal growth medium. The Ultraculture
serum-free medium was purchased from Cambrex.
Primary cultures of limb primordial cells were dissociated from the
stylopod and zeugopod region of the forelimb of E13.5 mouse
embryos; primary cultures of the calvarial cells were isolated from
2-day-old newborn mice. Cells were seeded at 1 3 105 cells/cm2 in
a-MEM with 10% bovine serum and were used without passage.
Primary cultures of the bone marrow stromal cells (BMSCs) were
isolated from the femur and the tibia of 5-week-old mice and were
plated in a-MEM with 15% bovine serum; medium was changed at
day 3 and day 6. Cells were passed once at days 7–8 and were
reseeded at 1 3 105 cells/cm2 for AP or mineralization assays.
Infections and Transfections
Viruses expressing GFP or Dkk1 were as previously described (Hu
et al., 2005). Viruses expressing Wnt7b, PKCd, PKCd-DC, GqI, or the
Dvl-2 derivatives were generated in the same manner, and all coex-
pressed nuclear GFP via an internal ribosome entry site (IRES). A
proper dilution of each virus stock in appropriate growth medium
was chosen to achieve >90% infection as per GFP detection. For in-
fections, cells were incubated at about 50% confluency in virus-con-
taining medium for 24 hr.
Transient transfections were performed with Lipofectamine (Invitro-
gen) and, in some cases, after cells were infected with viruses. Lucif-
erase and AP assays were performed at 48 hr after transfection.
Transfections of siRNA oligonucleotides were performed with si-
PORT Amine (Ambion). Four distinct siRNA duplexes each for Gaq
and Ga11 were individually tested; two in each case were found to
be effective and were used in experiments reported here. For PKCd,
a pool of four siRNA duplexes was used.
Osteoblast Differentiation Assays
AP expression was detected as previously described (Katagiri et al.,
1994). When inhibitors were used, cells were pretreated with the inhib-
itor in normal growth medium for 1 hr. For mineralization assays, con-
fluent cells were incubated in the presence of 50 mg/ml ascorbic acid
and 50mM b-glycerophosphate for 14–21 days. Real-time PCR for os-
teoblast markers was performed as previously described (Hu et al.,
2005).
Proteomics, Western Analyses, and Immunocytochemistry
For proteomics, ST2 cells were cultured inWnt3a or Lmedium for 24 hr
before total cell lysates were harvested by using a lysis buffer contain-
ing a protease inhibitor cocktail (Roche) and phosphatase inhibitor
cocktail 1 and 2 (Sigma). Proteomic analyses were performed at the
Siteman Cancer Center Proteomics Core Facility (Washington
University).
Western analyses were performed by using the ECL Plus Western
Blotting Detection System (Amersham Biosciences). The intensity of
protein bands was quantified with ImageJ (http://rsb.info.nih.gov/ij/).
For analyses of mutant embryos, E14.5 limbs were skinned, homoge-
nized, and extracted for cytosolic proteins in the presence of protease
and phosphatase inhibitors.
Immunocytochemistry was performed on chamber slides (Nalge
Nunc International). Cells seeded at 0.75 3 104/cm2 were cultured
overnight in regular medium, and then either directly switched to se-
rum-free medium for 24 hr or first infected with retroviruses before
changing to serum-free medium. Cells were then stimulated in fresh
serum-free medium for 30 min with recombinant Wnt3a protein at 50
ng/ml, and cells were finally immunostained and examined by confocal
microscopy.
Mouse Strains and Analyses
The PKCd+/ (Miyamoto et al., 2002), the Dermo1-Cre (Yu et al., 2003),
and the Wnt7b+/ (Parr et al., 2001) mouse strains were previouslyvier Inc.
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cessing, von Kossa staining, and in situ hybridization were performed
as described (Hilton et al., 2005). To quantitate relative bone length,
multiple sections representing different sectioning planes were stained
by von Kossa, and ratios of bone collar length over total length of the
element were calculated.
Supplemental Data
Supplemental Data include real-time PCR results showing the effects
of rottlerin on cells treated with Wnt3a and immunostaining results
showing Wnt3a-induced colocalization of PKCd with Dvl-1 and Dvl-3
and are available at http://www.developmentalcell.com/cgi/content/
full/12/1/113/DC1/.
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